Almac is uniquely positioned with a dedicated Biostatistics Group who are 100% focused on Randomisation and IXRS® Implementation / Support. The Biostatistics Group is comprised of experienced Biostatisticians and Biostatistics Data Managers.

Almac’s Biostatistics group offers randomisation consultancy upfront and across the study’s lifecycle:

•  Regulatory considerations of randomisation
•  Evaluation of blinding / potential for selection-bias
•  Selection of randomisation methodology and parameterisation
•  Treatment balance impact
•  IXRS® randomisation solutions for any type of study (from simple to complex)